Immunwork, Inc., today announced that it is presenting at Biotech Showcase™ 2023. This year, registered attendees can view Immunwork’s presentation live, and also access a recorded version. With 24x7 on-demand access, attendees can view recorded presentations at their convenience when scheduling does not allow viewing during the main event week.

Dr. Kun-Po Li, Manager of External Collaboration and Clinical Development, will be presenting Immunwork at Biotech Showcase on Monday, January 9th 2023. In the presentation, Dr. Li will introduce Immunwork’s innovative technology platforms of antibody-drug conjugate (ADC) and antibody-radionuclide conjugates (ARC), as well as the Series A+ fundraising plan for its spin-off company, T-E Meds Holding. “Our technology can generate site-specific conjugation ADC using an enzyme-free click reaction, and achieve high drug-to-antibody ratio and good stability.” Dr. Li said, “the preclinical drug candidates display strong efficacy in animal models of multiple myeloma or pancreatic cancer.”

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.

“We are delighted that Immunwork will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”

Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 15th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

Immunwork, Inc. is a preclinical stage biotech company focusing on the research and development of novel drugs to fulfill unmet medical needs. The proprietary technology platforms enable designs of “T-E” drug molecules, which contain targeting (T) and effector (E) moieties. Many of our drug candidates are based on “multi-arm linkers,” which include antibody-drug conjugates (ADCs), antibody-radionuclide conjugates (ARCs), and ultralong-acting therapeutic peptides. Focused therapeutic area include oncology, metabolic diseases, and cardiovascular diseases. Contacts

Contact: Dr. Kun-Po Li, Manager of External Collaboration and Clinical Development (